Vamorolone (VBP15) Clinical Trials in Duchenne (January 2017)
by: Parent Project Muscular Dystrophy
Vamorolone (VBP15) Clinical Trials in Duchenne (January 2017)
On January 18, 2017, PPMD was joined by ReveraGen BioPharma for a webinar discussion on vamorolone (VBP15) clinical trials in Duchenne. Dr. Eric Hoffman presented a brief history of the vamorolone program, explained current and anticipated clinical trials, and answered community questions.
by: Parent Project Muscular Dystrophy
